The Inhalable market within the context of Respiratory Drugs is a rapidly growing sector of the pharmaceutical industry. Inhalable drugs are administered directly to the lungs, allowing for rapid absorption and a more targeted delivery of medication. This type of drug delivery is particularly useful for treating respiratory conditions such as asthma, COPD, and cystic fibrosis. Inhalable drugs are also used to treat acute conditions such as bronchitis and pneumonia. Inhalable drugs are typically administered via a metered-dose inhaler (MDI) or a dry powder inhaler (DPI). MDIs are the most common type of inhaler, and they deliver a measured dose of medication in a pressurized aerosol form. DPIs are a newer type of inhaler, and they deliver a dry powder form of medication. The Inhalable market is highly competitive, with many large pharmaceutical companies offering a variety of inhalable drugs. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Novartis, Merck, and Boehringer Ingelheim. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
